This inventor holds 3 USPTO granted patents. Top assignees: Endoscopic Technologies, Inc., Edwards Lifesciences Corporation. Active years: 2009-2011.
Company Filing History:
2 out of 28 
1 out of 1,782 
Years Active: 2009-2011
Title: Mathew Williams: Innovator in Cardiac Ablation Technologies
Introduction
Mathew Williams is a notable inventor based in New York, NY (US), recognized for his contributions to cardiac ablation technologies. He holds a total of 3 patents, showcasing his innovative approach to treating cardiac arrhythmias, particularly atrial fibrillation.
Latest Patents
His latest patents include a conduction block verification probe and method of use. This invention provides devices and methods for the ablation of cardiac tissue, specifically targeting conditions such as atrial fibrillation. The devices are designed to ablate epicardial tissue near pulmonary veins, but they can also be adapted for other cardiac tissues. Key features of these devices include tissue contacting members that secure the ablation device to the epicardial tissue and ablation members that perform the tissue ablation. Some embodiments incorporate suction apertures to stabilize a beating heart during procedures. Additionally, his inventions may be utilized in veterinary or research contexts to address various heart conditions beyond atrial fibrillation.
Another significant patent involves ablative treatment of atrial fibrillation via the coronary sinus. This invention details instruments and techniques for accessing the heart wall through the coronary sinus while protecting major arteries from ablative energy. It provides methods for forming transmural lesions in the left atrium, such as the left isthmus block, from within the coronary sinus.
Career Highlights
Throughout his career, Mathew Williams has worked with prominent companies in the medical technology field, including Endoscopic Technologies, Inc. and Edwards Lifesciences Corporation. His work has significantly advanced the field of cardiac treatment, particularly in minimally invasive procedures.
Collaborations
Mathew has collaborated with esteemed professionals in the industry, including Arthur A Bertolero and Tamer Ibrahim. These collaborations have contributed to the development and refinement of his innovative technologies.
Conclusion
Mathew Williams stands out as a key inventor in the realm of cardiac ablation technologies, with a focus on improving treatment methods for atrial fibrillation. His patents reflect a commitment to advancing medical technology and enhancing patient care.